Sort
23,748 grants matching “melanoma”
Integrative Cancer Genomics: Drivers, Pathways and Drugs
$464,984Dana Pe'er · Columbia Univ New York Morningside · R01 · FY2016 · CA
Project 3: Integrative Computational Analysis of Tumor-Mediated Immunosuppression
$464,972Sylvia Katina Plevritis · Stanford University · U54 · FY2018 · CA
Mechanism of Intratumoral Transport of Particulate Drugs
$464,910Haifa Shen · Methodist Hospital Research Institute · R01 · FY2020 · CA
An innovative integrated computational framework using gene signatures for patient stratification
$464,640Chao Cheng · Baylor College Of Medicine · R01 · FY2023 · CA
Targeting TERT in Melanoma
$464,587Jessie Villanueva · Wistar Institute · R01 · FY2021 · CA
0-glycoprotein podoplanin in vascular development
$464,470Rodger Paul McEver · Oklahoma Medical Research Foundation · P01 · FY2014 · HL
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells
$464,426Hua Wang · University Of Illinois At Urbana-Champaign · R01 · FY2023 · CA
PATHOGENESIS OF FEVER IN HUMANS
$464,351University Of Colorado Denver · R01 · FY2002 · AI
MYC-dependent loss of splicing fidelity in Glioblastoma multiforme
$464,304Patrick Paddison · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
$464,275William E Gillanders · Washington University · P50 · FY2017 · CA
Targeting autophagy to enhance immune checkpoint inhibition
$464,236Ravi K Amaravadi · Wistar Institute · P50 · FY2024 · CA
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$464,112Jessie Villanueva · Wistar Institute · R01 · FY2024 · CA
CDKN2A couples lipid metabolism to ferroptosis in glioblastoma
$464,096David A. Nathanson · University Of California Los Angeles · R01 · FY2025 · NS
The regulation of melanocyte stem cells by Wnt signaling
$464,042Mayumi Ito · New York University School Of Medicine · R01 · FY2024 · AR
Chemical disruption of Wnt-mediated signal transduction
$464,007Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2015 · CA
Chemical disruption of Wnt-mediated signal transduction
$464,007Lawrence Lum · Ut Southwestern Medical Center · R01 · FY2016 · CA
Chemical disruption of Wnt-mediated signal transduction
$464,007James Kim · Ut Southwestern Medical Center · R01 · FY2017 · CA
3D Bioprinted skin models for drug screening
$463,965Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Comprehensive minimal residual disease tracking in cancer
$463,940G. Mike Makrigiorgos · Dana-Farber Cancer Inst · R01 · FY2024 · CA
ATF2 in DNA damage response.
$463,878Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2009 · CA
Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy
$463,816Timothy P Padera · Massachusetts General Hospital · R01 · FY2024 · CA
Nanoparticles to Track T Cell Immunotherapy Using Magnetic Particle Imaging
$463,812Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2024 · EB
Mechanism of Intratumoral Transport of Particulate Drugs
$463,570Haifa Shen · Methodist Hospital Research Institute · R01 · FY2021 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
$463,483Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Novel role of melanin-carbonyls in progression of NRAS mutant melanoma
$463,375Sanjay Premi · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2023 · ES